68
Views
0
CrossRef citations to date
0
Altmetric
Oncology

ESM1 May Be Used as a New Indicator for the Diagnosis and Prognosis of Early and Advanced Stage Digestive Tract Cancers

, , , , &
Pages 2809-2820 | Received 27 Dec 2023, Accepted 09 May 2024, Published online: 17 Jun 2024

References

  • Stoklosa P, Borgstrom A, Kappel S, Peinelt C. TRP Channels in Digestive Tract Cancers. Int J Mol Sci. 2020;21. doi:10.3390/ijms21051877
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
  • Xiao R, Wang S, Guo J, et al. Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma. J Cell Mol Med. 2022;26:1183–1193. doi:10.1111/jcmm.17171
  • Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–412. doi:10.1016/S0140-6736(12)60643-6
  • Yang L, Dong Z, Li S, Chen T. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression. Aging. 2023;15:2920–2936. doi:10.18632/aging.204559
  • De Freitas CN, Gaudet A, Portier L, Tsicopoulos A, Mathieu D, Lassalle P. Endocan, sepsis, pneumonia, and acute respiratory distress syndrome. Crit Care. 2018;22:280. doi:10.1186/s13054-018-2222-7
  • Lassalle P, Molet S, Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271:20458–20464. doi:10.1074/jbc.271.34.20458
  • Zeng M, Xie Z, Zhang J, Li S, Wu Y, Yan X. Arctigenin Attenuates Vascular Inflammation Induced by High Salt through TMEM16A/ESM1/VCAM-1 Pathway. Biomedicines. 2022;10:2760. doi:10.3390/biomedicines10112760
  • Vila-Gonzalez M, Kelaini S, Magee C, et al. Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 Signaling. Stem Cells. 2019;37:226–239. doi:10.1002/stem.2936
  • Li YK, Zeng T, Guan Y, et al. Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance. Int J Biol Sci. 2023;19:258–280. doi:10.7150/ijbs.66839
  • Cai H, Yang X, Gao Y, et al. Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer. Mol Ther Nucleic Acids. 2019;18:787–800. doi:10.1016/j.omtn.2019.09.023
  • Xu H, Chen X, Huang Z. Identification of ESM1 overexpressed in head and neck squamous cell carcinoma. Cancer Cell Int. 2019;19:118. doi:10.1186/s12935-019-0833-y
  • Li J, Yang D, Zhang C, et al. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma. Biomed Res Int. 2022;2022:5328192. doi:10.1155/2022/5328192
  • Kumar R, Indrayan A. Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr. 2011;48:277–287. doi:10.1007/s13312-011-0055-4
  • Cui Y, Guo W, Li Y, Shi J, Ma S, Guan F. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer. Esophagus. 2021;18:326–338. doi:10.1007/s10388-020-00796-9
  • Pan KF, Lee WJ, Chou CC, et al. Direct interaction of beta-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer. EMBO J. 2021;40:e105450. doi:10.15252/embj.2020105450
  • Huang YG, Wang Y, Zhu RJ, Tang K, Tang XB, Su XM. EMS1/DLL4-Notch Signaling Axis Augments Cell Cycle-Mediated Tumorigenesis and Progress in Human Adrenocortical Carcinoma. Front Oncol. 2021;11:771579. doi:10.3389/fonc.2021.771579
  • Liu W, Yang Y, He B, et al. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-kappaB/Cyclin D1 pathway. Ann Transl Med. 2021;9:533. doi:10.21037/atm-20-7005
  • Gu X, Zhang J, Shi Y, et al. ESM1/HIF‑1alpha pathway modulates chronic intermittent hypoxia‑induced non‑small‑cell lung cancer proliferation, stemness and epithelial‑mesenchymal transition. Oncol Rep. 2021;45:1226–1234. doi:10.3892/or.2020.7913
  • Li YK, Gao AB, Zeng T, et al. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. J Transl Med. 2024;22:46. doi:10.1186/s12967-023-04819-8
  • Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5:11–18. doi:10.3348/kjr.2004.5.1.11
  • Wang N, Zhu L, Wang L, Shen Z, Huang X. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Comput Struct Biotechnol J. 2022;20:3106–3119. doi:10.1016/j.csbj.2022.06.039
  • Laloglu E, Aksoy H, Aksoy Y, Ozkaya F, Akcay F. The determination of serum and urinary endocan concentrations in patients with bladder cancer. Ann Clin Biochem. 2016;53:647–653. doi:10.1177/0004563216629169
  • Manitta E, Fontes MI, Stokholm BS, et al. DNA Methylation and Gene Expression in Blood and Adipose Tissue of Adult Offspring of Women with Diabetes in Pregnancy-A Validation Study of DNA Methylation Changes Identified in Adolescent Offspring. Biomedicines. 2022;10. doi:10.3390/biomedicines10061244
  • Yang WE, Hsieh MJ, Lin CW, et al. Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression. Int J Med Sci. 2017;14:1094–1100. doi:10.7150/ijms.20414
  • Kang N, Liang X, Fan B, et al. Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. Cancers. 2022;14. doi:10.3390/cancers14225681
  • Kang YH, Ji NY, Lee CI, et al. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids. 2011;40:1003–1013. doi:10.1007/s00726-010-0729-6